AI Verdict
Both stocks have similar AI ratings. Review detailed metrics below.
BSX vs MDT Fundamental Comparison
| Metric | BSX | MDT |
|---|---|---|
| Revenue | $20.1B | $26.6B |
| Net Income | $2.9B | $3.6B |
| Net Margin | 14.4% | 13.4% |
| ROE | 12.0% | 7.3% |
| ROA | 6.6% | 3.9% |
| Current Ratio | 1.62x | 2.54x |
| Debt/Equity | 0.46x | 0.57x |
| EPS | $1.94 | $2.76 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
BSX vs MDT: Frequently Asked Questions
Is BSX or MDT a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), both stocks have similar ratings. BSX is rated BUY (80% confidence) while MDT is rated BUY (80% confidence). This is not investment advice.
How does BSX compare to MDT fundamentally?
BOSTON SCIENTIFIC CORP has ROE of 12.0% vs Medtronic plc's 7.3%. Net margins are 14.4% vs 13.4% respectively.
Which stock pays higher dividends, BSX or MDT?
BSX has a dividend yield of N/A or no dividend while MDT has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in BSX or MDT for long term?
For long-term investing, consider that BSX has BUY rating with 80% confidence, while MDT has BUY rating with 80% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about BSX vs MDT?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For BSX vs MDT, both AIs rate them similarly based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.